The Journal of Immunology, Vol 155, Issue 4 1972-1980, Copyright © 1995 by American Association of Immunologists

ARTICLES

Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor

JW Pierce, CA Jamieson, JL Ross and R Sen
Department of Biology, Brandeis University, Waltham, MA 02254, USA.

Expression of the IL-2R alpha gene is regulated by members of the c- Rel/NF-kappa B family of transcription factors binding to the kappa B site in the promoter. Previous work has not defined the role of individual members of the c-Rel family in the activation of the IL-2R alpha gene. Using the COS cell system, we were able to reconstitute the regulation of the IL-2R alpha promoter by expressing cloned Rel family members with serum response factor (SRF). We found that c-rel alone activated the IL-2R alpha promoter only weakly but worked with the p50 subunit of NF-kappa B (NFKB1) to give a higher level of expression. We showed that c-rel heterodimerizes with p50 and the amount of this heterodimer correlated with the level of IL-2R alpha gene expression. Our results provide evidence that c-rel/p50 heterodimers activate gene expression in the context of a cellular promoter. We show that c-rel or p65 can cooperate with SRF in the activation of this promoter and the transactivation by c-rel with SRF was enhanced by p50. Synergistic activation required both kappa B and CArG sites, and binding studies show that these adjacent sites can be occupied simultaneously. The transactivation observed with cloned transcription factors mimics the physiologic induction of the IL-2R alpha gene since multiple sequence elements cooperate to give gene activation. The data support the model that c-rel/p50 or p65 can cooperate with SRF to specifically target the expression of the IL-2R alpha gene in activated T cells.

This article has been cited by other articles:

				H. J. Han, M. J. Lim, Y. J. Lee, J. H. Lee, I. S. Yang, and M. Taub Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-{kappa}B Am J Physiol Renal Physiol, January 1, 2007; 292(1): F373 - F381. [Abstract] [Full Text] [PDF]

				A. O'Sullivan, H.-C. Chang, Q. Yu, and M. H. Kaplan STAT4 Is Required for Interleukin-12-induced Chromatin Remodeling of the CD25 Locus J. Biol. Chem., February 20, 2004; 279(8): 7339 - 7345. [Abstract] [Full Text] [PDF]

				J.-H. Yeh, S. Spicuglia, S. Kumar, A. Sanchez-Sevilla, P. Ferrier, and J. Imbert Control of IL-2R{alpha} gene expression: structural changes within the proximal enhancer/core promoter during T-cell development Nucleic Acids Res., May 1, 2002; 30(9): 1944 - 1951. [Abstract] [Full Text] [PDF]

				C. Zeng and A. R. Morrison Disruption of the actin cytoskeleton regulates cytokine-induced iNOS expression Am J Physiol Cell Physiol, September 1, 2001; 281(3): C932 - C940. [Abstract] [Full Text] [PDF]

				J.-H. Yeh, P. Lecine, J. A. Nunes, S. Spicuglia, P. Ferrier, D. Olive, and J. Imbert Novel CD28-Responsive Enhancer Activated by CREB/ATF and AP-1 Families in the Human Interleukin-2 Receptor {alpha}-Chain Locus Mol. Cell. Biol., July 15, 2001; 21(14): 4515 - 4527. [Abstract] [Full Text] [PDF]

				H.-C. Liou, Z. Jin, J. Tumang, S. Andjelic, K. A. Smith, and M.-L. Liou c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function Int. Immunol., March 1, 1999; 11(3): 361 - 371. [Abstract] [Full Text] [PDF]

				B. Kahn-Perles, C. Lipcey, P. Lecine, D. Olive, and J. Imbert Temporal and Subunit-specific Modulations of the Rel/NF-kappa B Transcription Factors Through CD28 Costimulation J. Biol. Chem., August 29, 1997; 272(35): 21774 - 21783. [Abstract] [Full Text] [PDF]

				N. S. Belaguli, L. A. Schildmeyer, and R. J. Schwartz Organization and Myogenic Restricted Expression of the Murine Serum Response Factor Gene. A ROLE FOR AUTOREGULATION J. Biol. Chem., July 18, 1997; 272(29): 18222 - 18231. [Abstract] [Full Text] [PDF]